Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1980 | 12-1979 | 12-1978 | |
| Sales | 2,558,637 | 2,250,824 | 1,882,628 |
| Cost of Goods | 1,023,515 | 873,184 | 714,289 |
| Gross Profit | 1,535,122 | 1,377,640 | 1,168,339 |
| Operating Expenses | 970,330 | 836,293 | 694,231 |
| Operating Income | 565,307 | 541,531 | 474,397 |
| Interest Expense | 18,442 | 11,474 | 17,867 |
| Other Income | 43,476 | 29,122 | 30,956 |
| Pre-tax Income | 590,341 | 559,179 | 487,486 |
| Income Tax | 248,367 | 225,503 | 207,234 |
| Net Income Continuous | 341,974 | 333,676 | 280,252 |
| Net Income | $341,974 | $333,676 | $280,252 |
| EPS Basic Total Ops | 0.28 | N/A | N/A |
| EPS Basic Continuous Ops | 0.28 | N/A | N/A |
| EPS Diluted Total Ops | 0.28 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.28 | N/A | N/A |
| EBITDA(a) | $565,307 | $541,531 | $474,397 |